Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of ICON Public Limited Company regarding a class action lawsuit due to alleged misleading statements and failure to disclose material information during the class period from July 27, 2023, to October 23, 2024 [1]. Allegations Summary - ICON is accused of suffering a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [1]. - The company's functional service provision and hybrid model offerings were deemed insufficient to protect against a significant market downturn [1]. - Requests for proposals from biotechnology customers were primarily used for price discovery, not indicative of actual client demand [1]. - Customers canceled contracts, limited engagements, delayed clinical trial work, and failed to enter new contracts at historical rates [1]. - ICON's two largest customers were diversifying their clinical research organization providers away from the company [1]. - As a result of the above issues, ICON's reported net new business awards and book-to-bill metrics misrepresented actual client demand [1]. - Consequently, ICON was tracking significantly below the 2024 revenue and EPS guidance issued during the class period, which lacked a reasonable factual basis [1]. Next Steps for Shareholders - Shareholders are encouraged to register for the class action by April 11, 2025, to participate in the case without any cost or obligation [2]. - Registered shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case lifecycle [2]. Firm's Mission - The Gross Law Firm aims to protect the rights of investors affected by deceit, fraud, and illegal business practices, ensuring companies adhere to responsible business practices [3].

Core Viewpoint - A securities class action lawsuit has been filed against ICON Public Limited Company for allegedly making materially false and misleading statements regarding its business operations and financial health during the Class Period from July 27, 2023, to October 23, 2024 [1]. Allegations of Misconduct - The lawsuit claims that ICON failed to disclose significant business losses due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's hybrid model offerings were inadequate to protect the company from a market downturn [2]. - Requests for proposals from biotechnology customers were reportedly used as price discovery tools rather than reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, reduced engagements, and delayed clinical trial work, impacting new contract opportunities [2]. - The two largest customers of ICON were diversifying their provider base away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - Positive statements made by ICON regarding its business prospects were claimed to be materially misleading [2]. Lead Plaintiff Process - Investors in ICON have until April 11, 2025, to seek appointment as a lead plaintiff representative in the class action [3]. - A lead plaintiff acts on behalf of all class members and selects counsel to represent the class [3]. - Participation as a lead plaintiff does not affect the ability to share in any recovery from the lawsuit [3].

Core Viewpoint - ICON Public Limited Company (NASDAQ: ICLR) is facing allegations of issuing materially false and misleading statements during the class period from July 27, 2023, to October 23, 2024, which has led to significant business losses and misrepresentation of client demand [3][4]. Group 1: Allegations Against ICON - The complaint alleges that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations impacting its client base [3]. - ICON's functional service provision and hybrid model offerings were insufficient to protect the company from a significant market downturn [3]. - Requests for proposals from biotechnology customers were primarily used as price discovery tools, not indicative of actual client demand [3]. - Customers canceled contracts, limited engagements, delayed clinical trial work, and failed to enter into new contracts at historical rates [3]. - ICON's two largest customers were diversifying their clinical research organization providers away from the company [3]. - As a result of the above factors, ICON's reported net new business awards and book-to-bill metrics materially misrepresented client demand for its services [3]. - Consequently, ICON was tracking materially below the 2024 revenue and EPS guidance issued during the class period, which lacked a reasonable factual basis [3]. Group 2: Class Action Details - Shareholders who purchased shares of ICLR during the class period are encouraged to contact the Gross Law Firm for possible lead plaintiff appointment [1][4]. - The deadline for shareholders to register for the class action is April 11, 2025 [4]. - Once registered, shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case lifecycle [4].

NEW YORK, March 24, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of ICON Public Limited Company (NASDAQ: ICLR).Shareholders who purchased shares of ICLR during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE: https://securitiesclasslaw.com/securities/icon-public-limited-company-loss-submission-form/?id=137689&from=4 CLASS PE ...

RADNOR, Pa., March 21, 2025 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against ICON Public Limited Company ("ICON") (NASDAQ: ICLR) on behalf of all purchasers of ICON ordinary shares between July 27, 2023 and October 23, 2024, inclusive (the "Class Period"). The lead plaintiff deadline is April 11, 2025.CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP:     If you suffered ICON losses, you may CLICK HERE  ...

Core Viewpoint - A class action securities lawsuit has been filed against ICON Public Limited Company, alleging securities fraud that negatively impacted investors between July 27, 2023, and October 23, 2024 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that ICON suffered a material loss of business due to customer cost reduction measures and funding limitations affecting its client base [2]. - It is alleged that ICON's service offerings were inadequate to protect the company from a significant market downturn [2]. - The requests for proposals from biotechnology customers were reportedly used as price discovery tools, not reflecting actual client demand [2]. - Customers of ICON are said to have canceled contracts, limited engagements, and delayed clinical trial work, impacting new contracts at historical rates [2]. - The two largest customers of ICON were diversifying their clinical research organization providers away from the company [2]. - As a result of these issues, ICON's reported business metrics misrepresented actual client demand for its services [2]. - The company was tracking significantly below its 2024 revenue and EPS guidance, which lacked a reasonable factual basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in ICON during the specified period have until April 11, 2025, to request appointment as lead plaintiff [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing substantial settlements for shareholders and is recognized as a leading firm in securities litigation [4].